NHS to offer second MenB vaccine after deadly Kent outbreak
NHS Will Provide Second MenB Vaccination Following Kent Outbreak
Following a meningitis B outbreak in Kent that claimed two lives and infected 19 others, the National Health Service (NHS) has announced plans to administer a second dose of the vaccine to nearly 12,000 individuals. This initiative will begin next week, targeting those who may have been exposed to the disease. The second dose is necessary to ensure full immunity, as the initial vaccination was offered to people in the affected area, including some university students and school pupils.
Eligibility and Clinic Locations
Appointments for the second dose will be available at multiple clinics across Canterbury, Faversham, and Ashford. Eligible individuals can schedule via an online booking system. The vaccination program initially focused on students residing in university accommodations and attendees of a nightclub linked to the outbreak. Subsequently, it expanded to include sixth form students from schools or colleges where cases were confirmed. Additional details on booking will be released starting Monday.
Protective Measures and Outbreak Context
The UK Health Security Agency (UKHSA) classified the situation as a national incident to coordinate resources, such as antibiotics, during the response. Health Secretary Wes Streeting labeled the outbreak “unprecedented,” highlighting the rapid spread among a large number of people. A 21-year-old university student and a sixth form pupil, Juliette Kenny, were among the fatalities. Preventative antibiotics were distributed to a broader group, with long lines forming at the University of Kent over several days.
“The outbreak has been unprecedented due to the number of people who became infected in a short time frame,” said Health Secretary Wes Streeting.
The MenB vaccine safeguards against most meningococcal group B strains in the UK. While the second dose must be administered at least four weeks after the first, it can be delayed if needed. The NHS previously offered MenB vaccinations to babies and young children as part of a routine program introduced in 2015. At that time, UK advisers deemed a catch-up campaign for teenagers less cost-effective, leading to the adoption of the MenACWY vaccine for that age group. However, the recent outbreak has prompted a reevaluation of this decision by independent experts in the Joint Committee on Vaccination and Immunisation (JCVI).
Expanded Vaccination Efforts
Initially, the targeted program prioritized students in university halls in Kent. It later included attendees of the local nightclub, Club Chemistry, where the outbreak is believed to have started. Additional groups, such as sixth form students at institutions with confirmed or suspected cases, were added to the list. NHS Kent and Medway emphasized that appointments will be accessible through various clinics and hubs, ensuring broad coverage for those in need.
